Live Price
Live Volume
Chart Volume 0
Volume 0
5 secViridian Therapeutics Market Segments
Regular Trading Hours
-1.01(-4.88%)
| Open | $20.61 |
|---|---|
| Close | $19.61 |
| Low | $19.11 |
| Low Change | -1.50 (-7.28%) |
| High | $20.61 |
| High Change | +0.00 (+0.00%) |
| Range | $1.50 |
| Volume | 1.368M |
| Dollar Volume | $26.82M |
Premarket
+0.02(+0.10%)
| Open | $20.51 |
|---|---|
| Close | $20.53 |
| Low | $20.51 |
| Low Change | 0.00 (0.00%) |
| High | $20.75 |
| High Change | +0.24 (+1.17%) |
| Range | $0.24 |
| Volume | 23.662K |
| Dollar Volume | $485.78K |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.36(+1.75%)
| Open | $20.59 |
|---|---|
| Close | $20.95 |
| Low | $20.59 |
| Low Change | 0.00 (0.00%) |
| High | $20.98 |
| High Change | +0.39 (+1.89%) |
| Range | $0.39 |
| Volume | 428.957K |
| Dollar Volume | $8.99M |
Regular Trading Hours Yesterday
+0.32(+1.58%)
| Open | $20.27 |
|---|---|
| Close | $20.59 |
| Low | $20.00 |
| Low Change | -0.27 (-1.33%) |
| High | $20.75 |
| High Change | +0.48 (+2.34%) |
| Range | $0.75 |
| Volume | 955.727K |
| Dollar Volume | $19.68M |
Premarket Yesterday
+0.17(+0.85%)
| Open | $20.10 |
|---|---|
| Close | $20.27 |
| Low | $19.75 |
| Low Change | -0.35 (-1.74%) |
| High | $20.27 |
| High Change | +0.17 (+0.85%) |
| Range | $0.52 |
| Volume | 16.067K |
| Dollar Volume | $325.68K |
Viridian Therapeutics News
3 months agoinvesting.comComcast, Viridian Therapeutics jump premarket; Doximity slips
- 5 months agoinvesting.com
Viridian Therapeutics stock surges on positive trial results
- 6 months agoinvesting.com
Viridian Therapeutics stock tumbles after Amgen Tepezza data
6 months agobloomberg.comUS Premarket Movers: Alcoa, Spire, Sysco, Viridian Therapeutics
- 6 months agoinvesting.com
Viridian Therapeutics stock tumbles despite trial success
Viridian Therapeutics Top Trades
Viridian Therapeutics's top trade so far today returned +2.59%, while the top short trade returned -7.90%.
Viridian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $20.46 |
|---|---|
| 10 Day Moving Average (SMA10) | $21.14 |
| 20 Day Moving Average (SMA20) | $21.80 |
| 50 Day Moving Average (SMA50) | $21.96 |
| 100 Day Moving Average (SMA100) | $19.74 |
| 200 Day Moving Average (SMA200) | $22.97 |
Viridian Therapeutics Statistics
| Average Volume (30 Days) | 1.5M |
|---|---|
| P/E Ratio (Current) | -6.78 |
| EPS (Current) | -$2.95 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$335.04M |
| Cash Ratio | 2.59 |
| Current Ratio | 16.95 |
| Quick Ratio | 16.95 |
| Debt to Equity | 0.54 |
| Enterprise Value | $2.46B |
| EV to EBITDA | -6.06 |
| EV to Sales | 34.54 |
| Price to Book | 3.42 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 31.86 |
| Return on Assets | -0.30% |
| Return on Equity | -0.50% |
Viridian Therapeutics Stock Splits
There have been 2 stock splits for Viridian Therapeutics (VRDN). The last reverse stock split occured on November 13, 2020 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Nov 13, 2020 | Reverse | 15:1 |
| Nov 7, 2016 | Reverse | 15:1 |
Viridian Therapeutics Dividends
There have been no dividends for Viridian Therapeutics (VRDN).